Chronic liver inflammation: Clinical implications beyond alcoholic liver disease

Byoung Jin Park, Yong Jae Lee, Hye Ree Lee

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Chronic alcohol exposure can lead to alcoholic liver disease, including hepatitis, cirrhosis and hepatocellular carcinoma, and chronic inflammation can simultaneously cause systemic medical illness. Recent evidence suggests that alcoholic liver disease is a predictor for liver-related diseases, cardiovascular disease, immunologic disease, and bone disease. Chronic inflammation in alcoholic liver disease is mediated by a direct inflammatory cascade from the alcohol detoxification process and an indirect inflammatory cascade in response to gut microflora-derived lipopolysaccharides (LPS). The pathophysiology of alcoholic liver disease and its related systemic illness is characterized by oxidative stress, activation of the immune cascade, and gut-liver interactions. Integrative therapeutic strategies for alcoholic liver disease include abstaining from alcohol consumption; general anti-inflammatories such as glucocorticoid, pentoxifylline, and tumour necrosis factor-α antagonist; antioxidants such as N- acetylcysteine; gut microflora and LPS modulators such as rifaximin and/or probiotics. This review focuses on the impact of chronic liver inflammation on systemic health problems and several potential therapeutic targets.

Original languageEnglish
Pages (from-to)2168-2175
Number of pages8
JournalWorld Journal of Gastroenterology
Volume20
Issue number9
DOIs
Publication statusPublished - 2014

Fingerprint

Alcoholic Liver Diseases
Inflammation
Liver
rifaximin
Lipopolysaccharides
Alcohols
Pentoxifylline
Bone Diseases
Immune System Diseases
Probiotics
Acetylcysteine
Alcohol Drinking
Glucocorticoids
Hepatitis
Liver Diseases
Hepatocellular Carcinoma
Oxidative Stress
Fibrosis
Anti-Inflammatory Agents
Cardiovascular Diseases

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

@article{d88aea60cc9f4312b8866b5f75e6e139,
title = "Chronic liver inflammation: Clinical implications beyond alcoholic liver disease",
abstract = "Chronic alcohol exposure can lead to alcoholic liver disease, including hepatitis, cirrhosis and hepatocellular carcinoma, and chronic inflammation can simultaneously cause systemic medical illness. Recent evidence suggests that alcoholic liver disease is a predictor for liver-related diseases, cardiovascular disease, immunologic disease, and bone disease. Chronic inflammation in alcoholic liver disease is mediated by a direct inflammatory cascade from the alcohol detoxification process and an indirect inflammatory cascade in response to gut microflora-derived lipopolysaccharides (LPS). The pathophysiology of alcoholic liver disease and its related systemic illness is characterized by oxidative stress, activation of the immune cascade, and gut-liver interactions. Integrative therapeutic strategies for alcoholic liver disease include abstaining from alcohol consumption; general anti-inflammatories such as glucocorticoid, pentoxifylline, and tumour necrosis factor-α antagonist; antioxidants such as N- acetylcysteine; gut microflora and LPS modulators such as rifaximin and/or probiotics. This review focuses on the impact of chronic liver inflammation on systemic health problems and several potential therapeutic targets.",
author = "Park, {Byoung Jin} and Lee, {Yong Jae} and Lee, {Hye Ree}",
year = "2014",
doi = "10.3748/wjg.v20.i9.2168",
language = "English",
volume = "20",
pages = "2168--2175",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "9",

}

Chronic liver inflammation : Clinical implications beyond alcoholic liver disease. / Park, Byoung Jin; Lee, Yong Jae; Lee, Hye Ree.

In: World Journal of Gastroenterology, Vol. 20, No. 9, 2014, p. 2168-2175.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Chronic liver inflammation

T2 - Clinical implications beyond alcoholic liver disease

AU - Park, Byoung Jin

AU - Lee, Yong Jae

AU - Lee, Hye Ree

PY - 2014

Y1 - 2014

N2 - Chronic alcohol exposure can lead to alcoholic liver disease, including hepatitis, cirrhosis and hepatocellular carcinoma, and chronic inflammation can simultaneously cause systemic medical illness. Recent evidence suggests that alcoholic liver disease is a predictor for liver-related diseases, cardiovascular disease, immunologic disease, and bone disease. Chronic inflammation in alcoholic liver disease is mediated by a direct inflammatory cascade from the alcohol detoxification process and an indirect inflammatory cascade in response to gut microflora-derived lipopolysaccharides (LPS). The pathophysiology of alcoholic liver disease and its related systemic illness is characterized by oxidative stress, activation of the immune cascade, and gut-liver interactions. Integrative therapeutic strategies for alcoholic liver disease include abstaining from alcohol consumption; general anti-inflammatories such as glucocorticoid, pentoxifylline, and tumour necrosis factor-α antagonist; antioxidants such as N- acetylcysteine; gut microflora and LPS modulators such as rifaximin and/or probiotics. This review focuses on the impact of chronic liver inflammation on systemic health problems and several potential therapeutic targets.

AB - Chronic alcohol exposure can lead to alcoholic liver disease, including hepatitis, cirrhosis and hepatocellular carcinoma, and chronic inflammation can simultaneously cause systemic medical illness. Recent evidence suggests that alcoholic liver disease is a predictor for liver-related diseases, cardiovascular disease, immunologic disease, and bone disease. Chronic inflammation in alcoholic liver disease is mediated by a direct inflammatory cascade from the alcohol detoxification process and an indirect inflammatory cascade in response to gut microflora-derived lipopolysaccharides (LPS). The pathophysiology of alcoholic liver disease and its related systemic illness is characterized by oxidative stress, activation of the immune cascade, and gut-liver interactions. Integrative therapeutic strategies for alcoholic liver disease include abstaining from alcohol consumption; general anti-inflammatories such as glucocorticoid, pentoxifylline, and tumour necrosis factor-α antagonist; antioxidants such as N- acetylcysteine; gut microflora and LPS modulators such as rifaximin and/or probiotics. This review focuses on the impact of chronic liver inflammation on systemic health problems and several potential therapeutic targets.

UR - http://www.scopus.com/inward/record.url?scp=84895868033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895868033&partnerID=8YFLogxK

U2 - 10.3748/wjg.v20.i9.2168

DO - 10.3748/wjg.v20.i9.2168

M3 - Article

C2 - 24605015

AN - SCOPUS:84895868033

VL - 20

SP - 2168

EP - 2175

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 9

ER -